Coagulation Changes Associated With COVID-19 Infection

Completed

Conditions studied: COVID, Disseminated Intravascular Coagulation, Coagulation Disorder

In brief

This study will study the potential utility of the Quantra QPlus System in patients inflicted with COVID-19 disease.

Key facts

Study ID

NCT04460664

Run by

HemoSonics LLC

People needed

15

Starts

2020-08-14

Expected to finish

2022-01-26

Last updated by the study team

2022-05-13

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Subject is ≥ 18 years of age
• Subject has a diagnosis of COVID-19 and has been admitted to the hospital
• Subject has one or more risk factors for a poor outcome with COVID-10 disease: advanced age (>=60 years), morbid obesity, diabetes, COPD, CAD
• Subject, or subject's legally authorized representative is willing and agrees to provide informed consent.

You may not qualify if…

• Subject is younger than 18 years of age
• Subject is pregnant
• Subject is incarcerated.
• Subject, or subject's legally authorized representative is unable or unwilling to provide informed consent.
• Subject is affected by a condition that, in the opinion of the treatment team, may pose additional risks.

Where it is running

• Texas Tech University Health Sciences Center El Paso — El Paso, Texas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.